Johann Rupert’s takeover of a leading South African private hospital group

Remgro CEO Jannie Durand said their takeover of Mediclinic Southern Africa shows long-term confidence in the local healthcare sector.

Durand shared his views on Remgro, controlled by billionaire Johann Rupert, becoming the sole shareholder of Mediclinic in a social media post.

The deal ended a complex deal between Remgro and Luxembourg-based Investment Holding Limited (IHL) to divide their shared stake in Mediclinic Holdings.

First announced in December 2025, this transaction had to overcome many regulatory hurdles in South Africa and Europe to reach completion.

Remgro and IHL were previously equal shareholders in Mediclinic Holdings. In December 2025, they reached an agreement to split their stakes.

On 1 July 2026, all conditions had been fulfilled. Remgro now owns 100% of the group’s Southern Africa operations, and IHL owns 100% of the Swiss-based operations.

Durand, who has been heading Rupert’s Remgro since 2012, said this deal marked another important chapter in their Mediclinic journey.

“This deal reflects our long-term confidence in healthcare as a sector that will continue to play a vital role in South Africa’s future,” he said.

He said that in 1983, Remgro supported the Mediclinic vision. What began in Stellenbosch has grown into one of Southern Africa’s leading private healthcare groups.

Today, Mediclinic serves millions of patients and supports thousands of healthcare professionals every year.

“Throughout our history, we have believed that enduring value is created by partnering with exceptional businesses,” Durand said.

“We are backing capable management teams and taking a long-term view when others are focused on shorter horizons. Mediclinic embodies those qualities.”

He said that it is a resilient business with a strong management team, deeply committed clinical staff and partner doctors.

“As custodians of this investment, our responsibility is not simply to preserve what has been built, but to support Mediclinic as it continues to evolve,” he said.

Healthcare is changing rapidly, driven by advances in technology, changing patient expectations and growing demand.

“We look forward to supporting the business as it navigates that future,” Durand said.